Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset
Related Posts
Mareninova OA, Chang AG, Hernandez Malpica S, Pineda JA, Mamita R, Shalbueva N, Gukovsky I, Gukovskaya AS. Genetic and pharmacologic modulations elucidate NRF2 protective role[...]
Hosseini-Carroll P, Dominitz JA, Jacobson BC, May FP, Issaka RB, Schmitt CM, Adams TL, Boston IJ, Bucobo JC, Day L, Khaykis IB, Marino MJ, Rex[...]
Keszthelyi D, Butt MF, Malcolm A, Reed D, Santucci N, Shin A, Visaggi P. Reflections on the Rome V Criteria for Disorders of the Gut-Brain[...]